Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

June 12, 2015November 5, 2015

Vertex Presents Data at European Cystic Fibrosis Society (ECFS) Conference on Orkambi Combo Therapy

Cystic Fibrosis, News

Vertex Pharmaceuticals recently announced results from its PROGRESS long-term extension trial that is evaluating the efficacy of the ORKAMBI (lumacaftor/ivacaftor) investigational regimen in patients with cystic fibrosis (CF). Cystic Fibrosis patients aged ... Read more

June 11, 2015November 9, 2015

Pulmonary Rehabilitation for Obstructive Sleep Apnea Presented at 2015 ATS Meeting

COPD, News

According to a recent study presented during the 2015 American Thoracic Society International Conference, Pulmonary Rehabilitation (PR) treatment could be beneficial when added to comprehensive therapy in patients suffering with ... Read more

June 9, 2015November 6, 2015

Canadian Researchers Find That Weight Loss in Obese Adults Reduces Asthma Severity

Asthma, News

In a recent study published in the journal CHEST, a team of researchers from the Department of Medicine at the Ottawa Hospital in Canada found that weight loss in obese ... Read more

June 5, 2015November 6, 2015

Accuracy of High Resolution Computed Tomography, Lung Function Tests in SSc Evaluated in New Study

News, Scleroderma

In a recent study published in the journal Arthritis & Rheumatology, researchers found that high resolution computed tomography (HRCT) predicts fibrosis development, rate of fibrosis progression and pulmonary function decline ... Read more

June 3, 2015November 5, 2015

ProMetic Confirms Anti-Fibrotic Effect of Experimental IPF Therapy in Human Kidney Cells

Idiopathic Pulmonary Fibrosis, News

ProMetic Life Sciences Inc., a biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development, recently presented in London at the annual meeting of the European Renal Association ... Read more

June 2, 2015November 5, 2015

FDA approves Pfizer’s RAPAMUNE To Stabilize Lung Function in Lymphangioleiomyomatosis

Idiopathic Pulmonary Fibrosis, News

Pfizer Inc. recently announced that the FDA has approved RAPAMUNE® (sirolimus) as the first treatment option for stabilizing lung function in patients with lymphangioleiomyomatosis (LAM), a rare, progressive disease that ... Read more

June 2, 2015November 6, 2015

Researchers Find Association Between Combined Bronchiectasis and Lung Cancer in Patients With COPD

Bronchiectasis, News

Results from a recent study published in the International Journal of Chronic Obstructive Pulmonary Disease show that the concomitant presence of bronchiectasis in patients with Chronic Obstructive Pulmonary Disease (COPD) is ... Read more

May 29, 2015November 9, 2015

FDA Approves Boehringer Ingelheim’s Stiolto Respimat as Maintenance Treatment for Patients With COPD

COPD, News

Boehringer Ingelheim announced that the FDA has approved once-daily Stiolto™ Respimat® (tiotropium bromide and olodaterol) Inhalation Spray. The drug was approved for long-term continuation therapy of the obstruction of the airflow in chronic ... Read more

May 27, 2015May 27, 2015

Risk Factors for Bronchiolitis Hospitalization in Preterm Newborns

Bronchiolitis, News

In a recent study published in the Italian Journal of Pediatrics, Silvia Vandini from the Foundation IRCCS Santa Lucia in Rome, Italy and colleagues evaluated the role of prenatal, perinatal and ... Read more

May 25, 2015November 5, 2015

RestorGenex Presents Results of Experimental Idiopathic Pulmonary Fibrosis Therapy

Idiopathic Pulmonary Fibrosis, News

RestorGenex, a biopharmaceutical company focused on developing a portfolio of first-in-class therapeutic products to treat diseases across the ophthalmologic, oncologic and dermatologic space, recently announced that Nathan Sandbo, M.D. and ... Read more